Posted in | News | Gold | Copper | Mining Business

Broadway Announces Commencement of Second Phase IP Survey at Madison Copper-Gold Project

Broadway Gold Mining Ltd. (TSX VENTURE: BRD) (OTCQB: BDWYF) (FRANKFURT: BGH) ("Broadway" or the "Company") is pleased to announce that Peter E. Walcott and Associates Limited has commenced a second phase, property-wide deep Induced Polarization (IP) survey to further delineate new targets identified in the first phase IP program at Broadway's Madison copper-gold project ("Madison") near Silver Star, Montana, USA in the Butte-Anaconda mining region. These surveys are searching for a suspected deeper copper-gold porphyry system beneath the shallower gold-copper skarn zones recently explored by the previous property owner. The new targets were identified in the IP survey completed in late 2016. Please see Broadway's news release of November 28, 2016.

The presence of a deeper porphyry system as the source for the shallower skarn mineralization has been speculated by previous explorers based on the presence of altered and mineralized intrusive in some of the historic drill holes. Nonetheless, historic drill programs through the 1980s focused on the gold potential of the oxidized skarn mineralization and the porphyry potential remained untested. The IP survey is probing Madison to a depth of 500 metres (1,640 feet).

Broadway began a Phase I 2017 surface drilling program in early January. Please see Broadway's news release of January 17, 2017.

Qualified Person

R. Tim Henneberry, P.Geo. and a Qualified Person as defined by NI 43-101 prepared and approved the technical information contained in this release. All geological information provided in this press release, including all information on the Madison Project, was gathered during the Company's due diligence process and has not been independently verified by management.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.